| 1 |
32416695 | High Prevalence of Vitamin D Deficiency and Correlation with Cystatin-C and Other Cardiovascular and Renal Risk Biomarkers in Patients with Type 2 Diabetes Mellitus Complicated with Hypertension. | 2021 |
1 |
| 2 |
33420892 | Vitamin D and parathyroid hormone status in community-dwelling elderly patients with mild-to-moderate kidney impairment. | 2021 May |
2 |
| 3 |
34362787 | Effect of Vitamin D Supplementation on Kidney Function in Adults with Prediabetes: A Secondary Analysis of a Randomized Trial. | 2021 Aug |
1 |
| 4 |
32183160 | Vitamin D3 Metabolites Demonstrate Prognostic Value in EGFR-Mutant Lung Adenocarcinoma and Can be Deployed to Oppose Acquired Therapeutic Resistance. | 2020 Mar 13 |
3 |
| 5 |
32610842 | Cross-sectional Study on Vitamin D Status in CKD Patients. | 2020 Apr |
3 |
| 6 |
30097651 | Association between vitamin D deficiency and lipid and non-lipid markers of cardiovascular diseases in the middle east region. | 2019 Jun |
2 |
| 7 |
31001917 | Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women. | 2019 May |
1 |
| 8 |
31326626 | Differential response of lung cancer cell lines to vitamin D derivatives depending on EGFR, KRAS, p53 mutation status and VDR polymorphism. | 2019 Oct |
2 |
| 9 |
29902012 | Tumor-Targeted Nanoparticles Deliver a Vitamin D-Based Drug Payload for the Treatment of EGFR Tyrosine Kinase Inhibitor-Resistant Lung Cancer. | 2018 Aug 6 |
2 |
| 10 |
30600944 | 25-hydroxyvitamin D Deficiency and Predictive Factors in Patients with Diabetic Nephropathy in Type 2 Diabetes Mellitus. | 2018 Jun |
2 |
| 11 |
26654942 | Diet-derived 25-hydroxyvitamin D3 activates vitamin D receptor target gene expression and suppresses EGFR mutant non-small cell lung cancer growth in vitro and in vivo. | 2016 Jan 5 |
3 |
| 12 |
26695721 | Vitamin D status during fetal life and childhood kidney outcomes. | 2016 May |
1 |
| 13 |
25294851 | The induction of C/EBPβ contributes to vitamin D inhibition of ADAM17 expression and parathyroid hyperplasia in kidney disease. | 2015 Mar |
2 |
| 14 |
26100522 | Impact of Short-term 1,25-Dihydroxyvitamin D3 on the Chemopreventive Efficacy of Erlotinib against Oral Cancer. | 2015 Sep |
1 |
| 15 |
26450935 | Plasma Vitamin D Level and Change in Albuminuria and eGFR According to Sodium Intake. | 2015 Dec 7 |
1 |
| 16 |
24641586 | Vitamin D resistance in chronic kidney disease (CKD). | 2014 Mar 19 |
1 |
| 17 |
24703961 | Estimated GFR and circulating 24,25-dihydroxyvitamin D3 concentration: a participant-level analysis of 5 cohort studies and clinical trials. | 2014 Aug |
1 |
| 18 |
25522365 | The application of the open pharmacological concepts triple store (open PHACTS) to support drug discovery research. | 2014 |
2 |
| 19 |
23364486 | The influence of renal function on vitamin D metabolism in the very elderly. | 2013 Feb |
1 |
| 20 |
23974111 | EGFR inhibitors exacerbate differentiation and cell cycle arrest induced by retinoic acid and vitamin D3 in acute myeloid leukemia cells. | 2013 Sep 15 |
2 |
| 21 |
24217116 | 1,25-Dihydroxyvitamin D3 (1,25(OH)2D3) Signaling Capacity and the Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer (NSCLC): Implications for Use of 1,25(OH)2D3 in NSCLC Treatment. | 2013 Nov 8 |
2 |
| 22 |
21458521 | The coupling of epidermal growth factor receptor down regulation by 1alpha,25-dihydroxyvitamin D3 to the hormone-induced cell cycle arrest at the G1-S checkpoint in ovarian cancer cells. | 2011 May 16 |
2 |
| 23 |
22468040 | Involvement of Depressive Catecholamines as Thrombosis Risk/Inflammatory Markers in Non-Smoker, Non-Obese Congestive Heart Failure, Linked to Increased Epidermal Growth Factor-Receptor (EGF-R) Production. | 2011 Apr |
3 |
| 24 |
20672448 | Tenofovir-linked hyperparathyroidism is independently associated with the presence of vitamin D deficiency. | 2010 Aug |
2 |
| 25 |
16087726 | Identification and characterization of a response element in the EGFR promoter that mediates transcriptional repression by 1,25-dihydroxyvitamin D3 in breast cancer cells. | 2005 Aug |
2 |
| 26 |
15218361 | Growth and EGFR regulation in breast cancer cells by vitamin D and retinoid compounds. | 2004 Jul |
7 |
| 27 |
15225829 | 1,25-Dihydroxyvitamin D downregulation of TGFalpha/EGFR expression and growth signaling: a mechanism for the antiproliferative actions of the sterol in parathyroid hyperplasia of renal failure. | 2004 May |
4 |
| 28 |
1677274 | Modulation of EGF receptor protooncogene expression by growth factors and hormones in human breast carcinoma cells. | 1991 |
1 |